Voloridge Investment Management »

Revance Therapeutics shares owned by Voloridge Investment Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Voloridge Investment Management from 13F filings

Historical chart of Voloridge Investment Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Voloridge Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 272k 8.79
2023-09-30 $6.2M 544k 11.47
2023-06-30 $11M 431k 25.31
2023-03-31 $5.3M 165k 32.21
2022-12-31 $4.8M 260k 18.46
2022-09-30 $15M 549k 27.00
2022-06-30 $4.2M 303k 13.82
2022-03-31 $4.0M 207k 19.50
2021-12-31 $3.6M 219k 16.32
2020-03-31 $204k 14k 14.83
2019-09-30 $254k 20k 13.01
2019-03-31 $318k 20k 15.78